CCDC68 and cancer: Pan-cancer analysis showed that CCDC68, FAM151A and MC1R were significantly different in thyroid cancer (THCA), renal clear cell carcinoma (RCC) and lung squamous cell carcinoma (LUSC) etc. (Fig. 12).